Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE

Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE

Peptide receptor radionuclide therapy (PRRT) of metastatic neuroendocrine tumors (NET) can be successfully repeated but may eventually be dose-limited. Since <sup>177</sup>Lu-DOTATATE dose limitation may come from hematological rather than renal function, hematological peripheral blood s...

Full description

Bibliographic Details
Main Authors: Amir Sabet, Nicolai Mader, Jörg Thomas Bittenbring, Fadi Khreish, Frank Grünwald, Hans Jürgen Biersack, Samer Ezziddin
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Pharmaceuticals
Subjects:
peptide receptor radionuclide therapy
PRRT
neuroendocrine tumor
NET
peripheral blood stem cell collection
PBSC
Online Access:https://www.mdpi.com/1424-8247/14/10/1022

Internet

https://www.mdpi.com/1424-8247/14/10/1022

Similar Items